Sfoglia per Rivista VACCINE
Herpes zoster prevention: A difficult problem to solve
2018-01-01 Esposito, Susanna; Principi, Nicola
Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule
2013-01-01 Rodgers, G. L.; Esposito, S.; Principi, N.; Gutierrez-Brito, M.; Diez-Domingo, J.; Pollard, A. J.; Snape, M. D.; Martinón-Torres, F.; Gruber, W. C.; Patterson, S.; Thompson, A.; Gurtman, A.; Paradiso, P.; Scott, D. A.
Immunization of bighorn sheep against Mannheimia haemolytica with a bovine herpesvirus 1-vectored vaccine
2017-01-01 Batra, Sai A.; Shanthalingam, Sudarvili; Donofrio, Gaetano; Haldorson, Gary J.; Chowdhury, Shafiqul; White, Stephen N.; Srikumaran, Subramaniam
Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen.
2011-01-01 Franceschi, Valentina; Capocefalo, Antonio; Calvo Pinilla, E; Redaelli, M; Mucignat Caretta, C; Mertens, P; Ortego, J; Donofrio, Gaetano
The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy
2016-01-01 Durando, P.; Esposito, S.; Bona, G.; Cuccia, M.; Desole, M. G.; Ferrera, G.; Gabutti, G.; Pellegrino, A.; Salvini, F.; Henry, O.; Povey, M.; Marchetti, F.
Immunogenicity and safety of intradermal influenza vaccine in children
2011-01-01 Esposito, Susanna Maria Roberta; C., Daleno; I., Picciolli; L., Tagliaferri; A., Scala; G., Prunotto; V., Montinaro; C., Galeone; N., Principi
Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months–2 years or 2–6 years primed with measles-mumps-rubella (MMR) vaccine
2009-01-01 Y., Gillet; G. C., Steri; U., Behre; J. P., Arsène; X., Lanse; K., Helm; Esposito, Susanna Maria Roberta; N., Meister; M. G., Desole; M., Douha; P., Willems
Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants
2005-01-01 Esposito, S.; Pugni, L.; Bosis, A.; Proto, A.; Cesati, L.; Bianchi, C.; Cimino, C.; Mosca, F.; Principi, N.
Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children
2016-01-01 Esposito, S.; Giavoli, C.; Trombetta, C.; Bianchini, S.; Montinaro, V.; Spada, A.; Montomoli, E.; Principi, N.
Immunogenicity, safety and tolerability of meningococcal C CRM197 conjugate vaccine administered 3, 5 and 11 months post-natally to pre- and full-term infants
2007-01-01 Esposito, Susanna Maria Roberta; B., Corbellini; S., Bosis; L., Pugni; E., Tremolati; C., Tagliabue; D., Toneatto; F., Mosca; N., Principi
Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis
2012-01-01 L., Dell'Era; F., Corona; C., Daleno; A., Scala; N., Principi; Esposito, Susanna Maria Roberta
Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major
2010-01-01 Esposito, Susanna Maria Roberta; E., D'Angelo; C., Daleno; F., Peia; A., Scala; D., Serra; N., Mirra; C., Galeone; N., Principi
Immunoprophylaxis pharmacotherapy against canine leishmaniosis: A systematic review and meta-analysis on the efficacy of vaccines approved in European Union
2020-01-01 Calzetta, L.; Pistocchini, E.; Ritondo, B. L.; Roncada, P.; Palma, E.; di Cave, D.; Mattei, M.; Britti, D.
Impact of a mixed bacterial lysate (OM-85 BV) on the immunogenicity, safety and tolerability of inactivated influenza vaccine in children with recurrent respiratory tract infection
2014-01-01 Esposito, Susanna Maria Roberta; P., Marchisio; E., Prada; C., Daleno; L., Porretti; R., Carsetti; A., Bosco; V., Ierardi; A., Scala; N., Principi
Impact of Haemophilus influenzae type b conjugate vaccination on hospitalization for invasive disease in children fifteen years after its introduction in Italy
2017-01-01 Martinelli, Domenico; Azzari, Chiara; Bonanni, Paolo; Esposito, Susanna; Franco, Elisabetta; Icardi, Giancarlo; Zuccotti, Gianvincenzo; Prato, Rosa
The impact of influenza vaccination on the COVID-19 pandemic? Evidence and lessons for public health policies
2020-01-01 Paget, J.; Caini, S.; Cowling, B.; Esposito, S.; Falsey, A. R.; Gentile, A.; Kyncl, J.; Macintyre, C.; Pitman, R.; Lina, B.
Impact of influenza-like illness and effectiveness of influenza vaccination in oncohematological children who have completed cancer therapy
2010-01-01 Esposito, Susanna Maria Roberta; V., Cecinati; B., Scicchitano; Delvecchio, G. C.; N., Santoro; D., Amato; C., Pelucchi; M., Jankovic; D., De Mattia; N., Principi
Influenza vaccination coverage among children with high-risk medical conditions
2006-01-01 Esposito, S.; Marchisio, P.; Droghetti, R.; Lambertini, L.; Faelli, N.; Bosis, S.; Tosi, S.; Begliatti, E.; Principi, N.
Influenza vaccination in healthy children
2007-01-01 N., Principi; Esposito, Susanna Maria Roberta
Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/2015 season
2016-01-01 Rizzo, Caterina; Bella, Antonino; Alfonsi, Valeria; Puzelli, Simona; Palmieri, Anna Pina; Chironna, Maria; Pariani, Elena; Piatti, Alessandra; Tiberti, Donatella; Rangoni, Roberto; Valeria, Ghisetti; Colucci, Maria Eugenia; Affanni, Paola; Germinario, Cinzia; Castrucci, Maria Rita
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Herpes zoster prevention: A difficult problem to solve | 1-gen-2018 | Esposito, Susanna; Principi, Nicola | |
Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule | 1-gen-2013 | Rodgers, G. L.; Esposito, S.; Principi, N.; Gutierrez-Brito, M.; Diez-Domingo, J.; Pollard, A. J.; Snape, M. D.; Martinón-Torres, F.; Gruber, W. C.; Patterson, S.; Thompson, A.; Gurtman, A.; Paradiso, P.; Scott, D. A. | |
Immunization of bighorn sheep against Mannheimia haemolytica with a bovine herpesvirus 1-vectored vaccine | 1-gen-2017 | Batra, Sai A.; Shanthalingam, Sudarvili; Donofrio, Gaetano; Haldorson, Gary J.; Chowdhury, Shafiqul; White, Stephen N.; Srikumaran, Subramaniam | |
Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen. | 1-gen-2011 | Franceschi, Valentina; Capocefalo, Antonio; Calvo Pinilla, E; Redaelli, M; Mucignat Caretta, C; Mertens, P; Ortego, J; Donofrio, Gaetano | |
The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy | 1-gen-2016 | Durando, P.; Esposito, S.; Bona, G.; Cuccia, M.; Desole, M. G.; Ferrera, G.; Gabutti, G.; Pellegrino, A.; Salvini, F.; Henry, O.; Povey, M.; Marchetti, F. | |
Immunogenicity and safety of intradermal influenza vaccine in children | 1-gen-2011 | Esposito, Susanna Maria Roberta; C., Daleno; I., Picciolli; L., Tagliaferri; A., Scala; G., Prunotto; V., Montinaro; C., Galeone; N., Principi | |
Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months–2 years or 2–6 years primed with measles-mumps-rubella (MMR) vaccine | 1-gen-2009 | Y., Gillet; G. C., Steri; U., Behre; J. P., Arsène; X., Lanse; K., Helm; Esposito, Susanna Maria Roberta; N., Meister; M. G., Desole; M., Douha; P., Willems | |
Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants | 1-gen-2005 | Esposito, S.; Pugni, L.; Bosis, A.; Proto, A.; Cesati, L.; Bianchi, C.; Cimino, C.; Mosca, F.; Principi, N. | |
Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children | 1-gen-2016 | Esposito, S.; Giavoli, C.; Trombetta, C.; Bianchini, S.; Montinaro, V.; Spada, A.; Montomoli, E.; Principi, N. | |
Immunogenicity, safety and tolerability of meningococcal C CRM197 conjugate vaccine administered 3, 5 and 11 months post-natally to pre- and full-term infants | 1-gen-2007 | Esposito, Susanna Maria Roberta; B., Corbellini; S., Bosis; L., Pugni; E., Tremolati; C., Tagliabue; D., Toneatto; F., Mosca; N., Principi | |
Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis | 1-gen-2012 | L., Dell'Era; F., Corona; C., Daleno; A., Scala; N., Principi; Esposito, Susanna Maria Roberta | |
Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major | 1-gen-2010 | Esposito, Susanna Maria Roberta; E., D'Angelo; C., Daleno; F., Peia; A., Scala; D., Serra; N., Mirra; C., Galeone; N., Principi | |
Immunoprophylaxis pharmacotherapy against canine leishmaniosis: A systematic review and meta-analysis on the efficacy of vaccines approved in European Union | 1-gen-2020 | Calzetta, L.; Pistocchini, E.; Ritondo, B. L.; Roncada, P.; Palma, E.; di Cave, D.; Mattei, M.; Britti, D. | |
Impact of a mixed bacterial lysate (OM-85 BV) on the immunogenicity, safety and tolerability of inactivated influenza vaccine in children with recurrent respiratory tract infection | 1-gen-2014 | Esposito, Susanna Maria Roberta; P., Marchisio; E., Prada; C., Daleno; L., Porretti; R., Carsetti; A., Bosco; V., Ierardi; A., Scala; N., Principi | |
Impact of Haemophilus influenzae type b conjugate vaccination on hospitalization for invasive disease in children fifteen years after its introduction in Italy | 1-gen-2017 | Martinelli, Domenico; Azzari, Chiara; Bonanni, Paolo; Esposito, Susanna; Franco, Elisabetta; Icardi, Giancarlo; Zuccotti, Gianvincenzo; Prato, Rosa | |
The impact of influenza vaccination on the COVID-19 pandemic? Evidence and lessons for public health policies | 1-gen-2020 | Paget, J.; Caini, S.; Cowling, B.; Esposito, S.; Falsey, A. R.; Gentile, A.; Kyncl, J.; Macintyre, C.; Pitman, R.; Lina, B. | |
Impact of influenza-like illness and effectiveness of influenza vaccination in oncohematological children who have completed cancer therapy | 1-gen-2010 | Esposito, Susanna Maria Roberta; V., Cecinati; B., Scicchitano; Delvecchio, G. C.; N., Santoro; D., Amato; C., Pelucchi; M., Jankovic; D., De Mattia; N., Principi | |
Influenza vaccination coverage among children with high-risk medical conditions | 1-gen-2006 | Esposito, S.; Marchisio, P.; Droghetti, R.; Lambertini, L.; Faelli, N.; Bosis, S.; Tosi, S.; Begliatti, E.; Principi, N. | |
Influenza vaccination in healthy children | 1-gen-2007 | N., Principi; Esposito, Susanna Maria Roberta | |
Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/2015 season | 1-gen-2016 | Rizzo, Caterina; Bella, Antonino; Alfonsi, Valeria; Puzelli, Simona; Palmieri, Anna Pina; Chironna, Maria; Pariani, Elena; Piatti, Alessandra; Tiberti, Donatella; Rangoni, Roberto; Valeria, Ghisetti; Colucci, Maria Eugenia; Affanni, Paola; Germinario, Cinzia; Castrucci, Maria Rita |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile